Caitlin John’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$654 Sell
8
-3
-27% -$242 ﹤0.01% 921
2026
Q1
$995 Hold
11
﹤0.01% 801
2025
Q4
$1.1K Hold
11
﹤0.01% 786
2025
Q3
$1.09K Buy
+11
New +$1.01K ﹤0.01% 758
2025
Q1
Sell
-11
Closed -$917 526
2024
Q4
$917 Sell
11
-79
-88% -$6.84K ﹤0.01% 743
2024
Q3
$7.96K Buy
90
+79
+718% +$6.65K 0.01% 511
2024
Q2
$904 Sell
11
-76
-87% -$6.23K ﹤0.01% 736
2024
Q1
$7.62K Hold
87
0.01% 503
2023
Q4
$7.27K Buy
+87
New +$6.63K 0.01% 490

Other funds holding MDT

Caitlin John's MDT Position: Q2 2026 in Review

Caitlin John reduced its Medtronic (MDT) stake by 27% in Q2 2026, selling an estimated $242 and leaving 8 shares worth $654. The position accounts for ﹤0.01% of the portfolio, ranked #921.

Caitlin John first reported a position in MDT in Q4 2023 and has held it in 9 quarters since. The position peaked at $7.96K in Q3 2024. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Caitlin John held 8 shares of Medtronic worth $654 as of Q2 2026.
  • Caitlin John sold 3 Medtronic shares in Q2 2026, an estimated $242.
  • Medtronic made up ﹤0.01% of Caitlin John's portfolio in Q2 2026, its #921 holding.
  • Caitlin John first reported a position in Medtronic in Q4 2023 and has held it in 9 quarters since.
  • Caitlin John's Medtronic position peaked at $7.96K in Q3 2024.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Caitlin John's 13F filing for Q2 2026, filed 17 Aug 2026.